Antibacterial and Antifungal Activity of Quaternary Ammonium Salts and their Heterocyclic Derivatives
Аннотация
Abstract— The rise of antimicrobial resistance in pathogenic microorganisms necessitates the search for novel biologically active compounds. Quaternary ammonium compounds (QACs) and their heterocyclic derivatives are of significant interest due to their membranotropic activity and ability to overcome resistance mechanisms. In this regard, the aim of the present study was to evaluate the antibacterial and antifungal activity of eight novel heterocyclic derivatives of quaternary ammonium salts against hospital strains of Escherichia coli , Staphylococcus aureus , and Candida albicans , as well as to establish structure–activity relationships. Antimicrobial activity was determined by the agar diffusion method according to the Russian Pharmacopoeia standard OFS 42-0068-07, using furadonin, furazolidone, and fluconazole as reference drugs. It was found that seven out of eight compounds exhibited pronounced antifungal activity against C. albicans with inhibition zones of 28–38 mm, exceeding fluconazole (25 mm). The most active were derivatives with bromophenyl fragments 7 (38 ± 2 mm) and 5 (36 ± 2 mm). Against S. aureus , compounds 6 , 7 , and 10 demonstrated zones of 40–42 mm, significantly surpassing furadonin and furazolidone (25 mm). Against E. coli , compounds 6 and 7 (26 ± 2 mm) were most effective, exceeding the activity of furadonin (19 mm). It was established that derivatives with bromophenyl fragments ( 5 and 7 ) possess an optimal balance of hydrophilicity and lipophilicity, providing maximal membranotropic activity. Thus, the developed approach enabled the obtainment of compounds with pronounced antimicrobial activity surpassing that of traditional drugs. The revealed membranotropic mechanism of action determines the potential of these compounds against resistant pathogen strains.